Naujienos, aktualijos, renginiai
Press release, 8 January 2020 On behalf of the Seimas and on his own behalf, Viktoras Pranckietis, Speaker of the Seimas, extended sincere condolences to Dmytro Razumkov, Chairman of the Verkhovna Rada of Ukraine, on the disaster of the Ukraine International Airlines aircraft in Tehran. ‘We share your pain and the pain of the people … Skaityti toliau
Aachen, Germany / Morristown, New Jersey, USA – Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza® (8 % capsaicin) for Grünenthal in the US. Grünenthal had only recently acquired the remaining global … Skaityti toliau
Aachen, Germany, 5 November 2018 – Grünenthal, the science-focused pharmaceutical company based in Germany, announced today that it has acquired additional global commercial rights for the dermal pain patch Qutenza® (8% capsaicin) from Acorda Therapeutics, Inc (USA). Grünenthal is now the sole owner of Qutenza® worldwide, including the US, Latin America, Asia and Australia. Grünenthal … Skaityti toliau
Biggest single investment in Grünenthal’s history that will significantly strengthen the company’s leading position in pain management Gastroprotective therapies to address a high unmet medical need[1] in pain patients on non-steroidal anti-inflammatory drugs (NSAIDs) Aachen, Germany, 30 October 2018 – Grünenthal today announced that it has agreed to acquire AstraZeneca’s European rights to Nexium and … Skaityti toliau
October 19, 2018 – Geneva, Switzerland Osteoporosis, a disease which causes bones to become weak and fragile, is the cause of broken bones in approximately one in three women and one in five men aged over 50 worldwide. Spine (or ‘vertebral’) fractures are the most common osteoporotic fractures – with one new fracture estimated to … Skaityti toliau
Osteoarthritis (OA) of the knee affects 10-15 percent of adults aged over 60 years worldwide (WHO, 2013). There are surgical and non-surgical treatment options. Medicines like hyaluronic acid, corticosteroids, platelet-rich plasma or autologous conditioned serum (ACS/ Orthokine®) can be injected directly into the joint. The Spanish team of Dr. Jaime Baselga García-Escudero and Dr. Pedro … Skaityti toliau